Park Ha Biological Technology Co., Ltd. PHH
0.39 0.00 (+0.00%)
At closeOct 27, 2025, 4:00 PM EDT
0.3825 Day range 0.4235
52-week range unavailable
- YTD
- -93.88%
- 1 year
- -90.54%
- Market cap
- 9.96M
- Revenue (ttm)
- 2.38M
- Profit margin
- 20.09%
- Shares out
- 26.37M
- YTD return
- -93.88%
- 1-year return
- -90.54%
- Volume
- 428.94K
- Open
- 0.3916
- Previous close
- 0.385
- Day's range
- 0.3825 – 0.4235
No chart data for this range yet.
Key statistics
- Enterprise value
- 922.36M
- PEG ratio
- 0.00
- Price / sales
- 33.11
- Price / book
- 49.83
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 40.60%
- Free cash flow
- -435.10K
- Total cash
- 547.50K
- Total debt
- 70.32K
- Return on equity
- 38.00%
- Short % of float
- 0.81%
- 50-day average
- 19.75
- 200-day average
- 12.58
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
PHH Revenue — quarterly 35.00M
PHH Net income — quarterly -35.00M
PHH EPS — quarterly -1.07
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- China
- Website
- parkha.cn
News
PHH, BYAH Deadline: Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights 
PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH 
PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH 
PHH, BYAH DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH 
Portnoy Law Firm Announces Class Action on Behalf of Park Ha Biological Technology Co., Inc. Investors 
PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit 
PHH, BYAH DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH 
PHH, BYAH FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH 
PARK HA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH 
PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit
Your note
Sign in to keep a note on PHH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN WILLIAM F | General Counsel | Sale | Dec 14, 2017 | 83,412 |
| CARLIN JANE D | Director | Stock Award(Grant) | Jun 27, 2017 | 34,228 |
| EGAN JAMES O | Director | Sale | Sep 10, 2017 | 34,868 |
| GIBBONS THOMAS P | Director | Stock Award(Grant) | Jun 8, 2016 | 31,582 |
| KAPLAN LEITH W | Officer | Sale | Nov 9, 2017 | 64,400 |
| NEUHAUSER JAMES C | Director | Stock Award(Grant) | Jun 27, 2017 | 7,942 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.00% | 16,785 | 50.19K | Mar 30, 2025 |
| Citadel Advisors Llc | 0.00% | 16,606 | 49.65K | Mar 30, 2025 |
| HRT Financial LP | 0.00% | 14,787 | 44.21K | Mar 30, 2025 |
| Royal Bank of Canada | 0.00% | 2,262 | 6.76K | Mar 30, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.00% | 16,785 | 50.19K | May 30, 2025 |